首页> 外文OA文献 >Toxicity Testing in the 21st Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways
【2h】

Toxicity Testing in the 21st Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways

机译:21世纪的毒性测试:基于扰动细胞内毒性途径定义新的风险评估方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The approaches to quantitatively assessing the health risks of chemical exposure have not changed appreciably in the past 50 to 80 years, the focus remaining on high-dose studies that measure adverse outcomes in homogeneous animal populations. This expensive, low-throughput approach relies on conservative extrapolations to relate animal studies to much lower-dose human exposures and is of questionable relevance to predicting risks to humans at their typical low exposures. It makes little use of a mechanistic understanding of the mode of action by which chemicals perturb biological processes in human cells and tissues. An alternative vision, proposed by the U.S. National Research Council (NRC) report Toxicity Testing in the 21st Century: A Vision and a Strategy, called for moving away from traditional high-dose animal studies to an approach based on perturbation of cellular responses using well-designed in vitro assays. Central to this vision are (a) “toxicity pathways” (the innate cellular pathways that may be perturbed by chemicals) and (b) the determination of chemical concentration ranges where those perturbations are likely to be excessive, thereby leading to adverse health effects if present for a prolonged duration in an intact organism. In this paper we briefly review the original NRC report and responses to that report over the past 3 years, and discuss how the change in testing might be achieved in the U.S. and in the European Union (EU). EU initiatives in developing alternatives to animal testing of cosmetic ingredients have run very much in parallel with the NRC report. Moving from current practice to the NRC vision would require using prototype toxicity pathways to develop case studies showing the new vision in action. In this vein, we also discuss how the proposed strategy for toxicity testing might be applied to the toxicity pathways associated with DNA damage and repair.
机译:在过去的50到80年中,定量评估化学暴露对健康的危害的方法没有发生明显的变化,重点仍然放在测量均质动物种群不良结局的高剂量研究上。这种昂贵的低通量方法依赖于保守的推断,将动物研究与低剂量的人类暴露联系起来,并且与预测在典型的低暴露水平下对人类的风险有关。它很少使用对化学物质干扰人体细胞和组织中生物过程的作用方式的机械理解。美国国家研究委员会(NRC)报告的《 21世纪的毒性测试:远景与策略》提出了另一种远景,呼吁从传统的大剂量动物研究转为基于对细胞反应进行干扰的方法。设计的体外测定。该愿景的核心是(a)“毒性途径”(可能受到化学物质干扰的先天细胞途径)和(b)确定可能引起过度干扰的化学物质浓度范围,如果对健康造成不利影响在完整的生物体中长期存在。在本文中,我们简要回顾了NRC的原始报告以及过去三年中对该报告的回应,并讨论了如何在美国和欧盟(EU)中实现测试方面的改变。欧盟在开发化妆品成分动物试验替代品方面的举措与NRC报告非常平行。从当前的实践过渡到NRC愿景,将需要使用原型毒性途径来开发案例研究,以证明新愿景正在发挥作用。因此,我们还将讨论拟议的毒性测试策略如何应用于与DNA损伤和修复相关的毒性途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号